Home›Antineoplastic and Immunomodulating Agents›Approval Status›ApprovedBrowse ByApprovedThis dimension marks a drug's current approval status, approved, withdrawn or investigational. Wikipedia notes that "governments generally regulate what drugs can be marketed, how drugs are marketed, and in some jurisdictions, drug pricing," regulation that always includes a formal approval decision. Browsing by approval status separates drugs currently approved from those that are not.FactsApprovedSourcesComments (0)Reader Challenges (0)FactsComparisonATC Level 1 CodeWell-attestedSourced to the subject's own accountL - Antineoplastic and immunomodulating agents 1ApprovedFilter Results62 entriesATC ClassAllL: Antineoplastic and Immunomodulating Agents (61)S: Sensory Organs (1)Route of AdministrationAllIntratumoral (2)Intravenous (31)Intravesical (1)Ophthalmic (1)Oral (20)Subcutaneous (6)Topical (2)Era (First Approved)All1947 (1)1949 (1)1959 (1)1963 (1)1964 (1)1969 (2)1973 (2)1974 (1)1975 (1)1976 (1)1977 (1)1978 (1)1983 (2)1992 (1)1994 (1)1999 (2)2001 (1)2002 (1)2004 (1)2005 (2)2010 (1)2013 (1)2015 (2)2016 (1)2017 (2)2018 (3)2019 (1)2020 (5)2021 (7)2022 (2)2023 (4)2024 (4)2025 (2)2026 (1)WHO Essential MedicineAllComplementary List (15)Treats (Condition)AllArthritis (1)Breast Cancer (1)Cancer (2)COVID-19 (1)Giant cell arteritis (1)Graft-Versus-Host Disease (1)Hidradenitis Suppurativa (1)Osteopetrosis (1)Psoriasis (1)Rheumatoid Arthritis (1)Severe Acute Respiratory Syndrome (1)Uveitis (1)Wilms Tumor (1)Show ResultsBrowseCompareSelect all 50AbraxaneApprovedActemraApprovedAdalimumabApprovedAllogeneic processed thymus tissueApprovedAllogeneic umbilical cord-derived CD34- cells, non-expanded/dorocubicelApprovedAmivantamab/hyaluronidaseApprovedAxicabtagene ciloleucelApprovedBevacizumabApprovedBinimetinibApprovedBleomycinApprovedBrexucabtagene autoleucelApprovedBrigatinibApprovedCarmustineApprovedCiclosporinApprovedCisplatinApprovedCobimetinibApprovedCytarabineApprovedDacarbazineApprovedDactinomycinApprovedDecitabine/cedazuridineApprovedEncorafenibApprovedEtoposideApprovedFedratinibApprovedFruquintinibApprovedIdecabtagene vicleucelApprovedImatinibApprovedInterferon gamma-1bApprovedInterleukin 2ApprovedLifileucelApprovedLisocabtagene maraleucelApprovedLomustineApprovedMelphalan flufenamideApprovedMethotrexateApprovedMitomycin CApprovedMotixafortideApprovedNadofaragene firadenovecApprovedNiraparib/abiraterone acetateApprovedNitrogen mustardApprovedOmidubicelApprovedPanobinostatApprovedProcarbazineApprovedRemestemcelApprovedRipretinibApprovedRucaparibApprovedSacituzumab govitecanApprovedSepsivacApprovedSugemalimabApprovedTabelecleucelApprovedTagraxofuspApprovedTamoxifenApprovedShowing 1 to 50 of 62, page 1 of 2.12Next →Sources1. Anatomical Therapeutic Chemical Classification System (Wikipedia)tier 3WikipediaATC Level 1 codes table, group LQuote, ATC Level 1 codes table, group LL - "Antineoplastic and immunomodulating agents"View the SourceComments (0)No comments yet. Be the first to share a thought.Sign in to join the discussion.Reader Challenges (0)No disputes yet. Spotted an error or a better source? Open the first one.Sign in to dispute this or suggest a correction.